While this phenomenon has not been extensively reported in [68Ga]Ga-FAPI PET/CT within the molecular imaging domain, previous immunohistochemistry research has revealed that HCC can exhibit FAP-immunostain negativity in 20% of cases [15]. The gene discussed is FAP; the disease is hepatocellular carcinoma.